ATHA Energy Announces Appointment of Ryan Gaffney as Senior Vice President, Business Development
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — ATHA Energy Corp. (CSE: SASK) (FRA: X5U) (OTCQB: SASKF) (“ATHA” or […]
Refined Metals Corp. and Eagle Plains Resources Enter into an Option Agreement for the Dufferin Project in the Athabasca Basin
VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) — Refined Metals Corp. (CSE: RMC; OTC: RFMCF; FRA: CWA0) (the “Company”) […]
AutoZone 2nd Quarter Total Company Same Store Sales Increase 1.5%; Domestic Same Store Sales Increase 0.3%; EPS Increases to $28.89
MEMPHIS, Tenn., Feb. 27, 2024 (GLOBE NEWSWIRE) — AutoZone, Inc. (NYSE: AZO) today reported net sales of $3.9 billion for […]
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
RESEARCH TRIANGLE PARK, N.C., Feb. 27, 2024 (GLOBE NEWSWIRE) — Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company […]
Olaplex Holdings, Inc. Announces Participation in the Raymond James 45th Annual Institutional Investors Conference on March 5th
SANTA BARBARA, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) — Olaplex Holdings, Inc. (“OLAPLEX”), today announced their participation in the Raymond […]
Ocwen Financial Announces Full Year and Fourth Quarter 2023 Results
Net loss of $64 million for 2023, driven by $89 million reduction in unrealized MSR value change due to rates […]
Lilium releases Full Year and Fourth Quarter 2023 Shareholder Letter
MUNICH, Germany, Feb. 27, 2024 (GLOBE NEWSWIRE) — Lilium N.V. (Nasdaq: LILM) (“Lilium”), developer of the first all-electric vertical take-off […]
Syntec Optics (Nasdaq: OPTX) Enabling Optics for Blindness
ROCHESTER, NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) — Syntec Optics, a scientific technical instruments, aerospace and defense optics provider […]
Synaptics Announces Chief Financial Officer Transition
SAN JOSE, Calif., Feb. 27, 2024 (GLOBE NEWSWIRE) — Synaptics® Incorporated (Nasdaq: SYNA) today announced the resignation of its Chief […]
SpringWorks Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Updates
– Reported OGSIVEO™ (nirogacestat) net product revenue of $5.4 million in first partial quarter of launch following FDA approval on […]
